Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease

Abstract

Background

Serologic testing for celiac disease includes tissue transglutaminase and endomysial antibodies. In addition to these tools, assays for deamidated gliadin peptide antibodies have been shown to have sensitivity and specificity that are comparable to tissue transglutaminase testing, and are increasingly being used for celiac disease testing.

Aims

The goal of this study is to evaluate the utility of deamidated gliadin peptide (DGP) testing in the setting of a negative tissue transglutaminase (TTG) IgA test.

Methods

We reviewed the records of all patients seen at two U.S. celiac disease referral centers and identified those who had an elevated DGP IgA and/or IgG in the setting of a negative TTG IgA. Of these patients, those who underwent duodenal biopsy while on a gluten-containing diet were included. Patients with prior biopsy-proven celiac disease or prior TTG IgA positivity were excluded. The results of the biopsy were used as the gold standard for celiac disease diagnosis, and patients with villous atrophy (Marsh class 3) on duodenal biopsy were considered to have celiac disease.

Results

Between the two institutions, 84 patients were identified with negative TTG IgA and positive DGP IgA or IgG who also had duodenal biopsies performed while maintaining a gluten-containing diet. Of these patients, 13 patients (15.5%; 95% CI 8.5–25.0%) were found to have celiac disease on duodenal biopsy.

Conclusions

DGP antibody testing can identify cases of celiac disease in TTG-negative individuals, although the low positive predictive value suggests that the yield may be low.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–354.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–676.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Prince HE. Evaluation of the INOVA diagnostics enzyme-linked immunosorbent assay kits for measuring serum immunoglobulin G (IgG) and IgA to deamidated gliadin peptides. Clin Vaccine Immunol. 2006;13:150–151.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Sugai E, Vazquez H, Nachman F, Moreno ML, et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol. 2006;4:1112–1117.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Oyaert M, Vermeersch P, De Hertogh G, Hiele M, et al. Combining antibody tests and taking into account antibody levels improves serologic diagnosis of celiac disease. Clin Chem Lab Med. 2015;53:1537–1546.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Vermeersch P, Geboes K, Marien G, Hoffman I, Hiele M, Bossuyt X. Serological diagnosis of celiac disease: comparative analysis of different strategies. Clin Chim Acta. 2012;413:1761–1767.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Sugai E, Hwang HJ, Vazquez H, Smecuol E, et al. New serology assays can detect gluten sensitivity among enteropathy patients seronegative for anti-tissue transglutaminase. Clin Chem. 2010;56:661–665.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Niveloni S, Sugai E, Cabanne A, Vazquez H, et al. Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease. Clin Chem. 2007;53:2186–2192.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Volta U, Granito A, Parisi C, Fabbri A, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol. 2010;44:186–190.

    Article  PubMed  Google Scholar 

  10. 10.

    Naiyer AJ, Hernandez L, Ciaccio EJ, Papadakis K, et al. Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol. 2009;43:225–232.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther. 2010;31:73–81.

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Sakly W, Mankai A, Ghdess A, Achour A, Thabet Y, Ghedira I. Performance of anti-deamidated gliadin peptides antibodies in celiac disease diagnosis. Clin Res Hepatol Gastroenterol. 2012;36:598–603.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Schyum AC, Rumessen JJ. Serological testing for celiac disease in adults. United Eur Gastroenterol J. 2013;1:319–325.

    Article  Google Scholar 

  14. 14.

    Sugai E, Moreno ML, Hwang HJ, Cabanne A, et al. Celiac disease serology in patients with different pretest probabilities: is biopsy avoidable? World J Gastroenterol. 2010;16:3144–3152.

    Article  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Abrams JA, Brar P, Diamond B, Rotterdam H, Green PH. Utility in clinical practice of immunoglobulin a anti-tissue transglutaminase antibody for the diagnosis of celiac disease. Clin Gastroenterol Hepatol. 2006;4:726–730.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Barada K, Habib RH, Malli A, Hashash JG, et al. Prediction of celiac disease at endoscopy. Endoscopy. 2014;46:110–119.

    Article  PubMed  Google Scholar 

  17. 17.

    Kurppa K, Lindfors K, Collin P, Saavalainen P, et al. Antibodies against deamidated gliadin peptides in early-stage celiac disease. J Clin Gastroenterol. 2011;45:673–678.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Vermeersch P, Richter T, Hauer AC, Stern M, et al. Use of likelihood ratios improves clinical interpretation of IgG and IgA anti-DGP antibody testing for celiac disease in adults and children. Clin Biochem. 2011;44:248–250.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Wang N, Truedsson L, Elvin K, Andersson BA, et al. Serological assessment for celiac disease in IgA deficient adults. PLoS ONE. 2014;9:e93180.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Benjamin Lebwohl.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest and nothing to declare.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hoerter, N.A., Shannahan, S.E., Suarez, J. et al. Diagnostic Yield of Isolated Deamidated Gliadin Peptide Antibody Elevation for Celiac Disease. Dig Dis Sci 62, 1272–1276 (2017). https://doi.org/10.1007/s10620-017-4474-5

Download citation

Keywords

  • Celiac disease
  • Gliadin
  • Tissue transglutaminase
  • Serologic tests